Epigenetic downregulation of the ISG15-conjugating enzyme UbcH8 impairs lipolysis and correlates with poor prognosis in nasopharyngeal carcinoma

Oncotarget. 2015 Dec 1;6(38):41077-91. doi: 10.18632/oncotarget.6218.

Abstract

We identified the UBE2L6 gene, encoding the ISG15-conjugating enzyme UbcH8, as one gene significantly downregulated by promoter hypermethylation in nasopharyngeal carcinoma (NPC). Reduced expression of the UbcH8 protein correlated with poor outcome in NPC patients. Restored expression of UBE2L6 suppressed proliferation and colony formation in NPC cells, while inducing apoptosis. Of particular interest, we found that aberrant lipid turnover was controlled by UbcH8 in NPC through ISG15-conjugation of valosin-containing protein (VCP). Tumor tissue and NPC cell lines showed conspicuously strong accumulation of lipid droplets (LDs) compared to control nasopharyngeal epithelium and non-cancerous cell lines. We demonstrated that UbcH8 counteracts degradation of adipocyte triglyceride lipase (ATGL), a key enzyme in lipid catabolism.

Keywords: ATGL; DNA methylation; UBE2L6; nasopharyngeal carcinoma; tumor suppressor gene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphatases / genetics
  • Adenosine Triphosphatases / metabolism
  • Apoptosis / genetics
  • Azacitidine / analogs & derivatives
  • Azacitidine / pharmacology
  • Blotting, Western
  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / metabolism
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Cytokines / genetics
  • Cytokines / metabolism
  • DNA Methylation
  • Decitabine
  • Down-Regulation*
  • Enzyme Inhibitors / pharmacology
  • Epigenesis, Genetic*
  • Gene Expression Profiling / methods
  • Gene Expression Regulation, Neoplastic / drug effects
  • HEK293 Cells
  • Humans
  • Kaplan-Meier Estimate
  • Lipase / genetics
  • Lipase / metabolism
  • Lipid Droplets / metabolism
  • Lipolysis / genetics*
  • Nasopharyngeal Neoplasms / genetics*
  • Nasopharyngeal Neoplasms / metabolism
  • Nasopharyngeal Neoplasms / pathology
  • Prognosis
  • Promoter Regions, Genetic
  • RNA Interference
  • Reverse Transcriptase Polymerase Chain Reaction
  • Ubiquitin-Conjugating Enzymes / genetics*
  • Ubiquitin-Conjugating Enzymes / metabolism
  • Ubiquitins / genetics
  • Ubiquitins / metabolism
  • Valosin Containing Protein

Substances

  • Cell Cycle Proteins
  • Cytokines
  • Enzyme Inhibitors
  • Ubiquitins
  • ISG15 protein, human
  • Decitabine
  • UBE2L6 protein, human
  • Ubiquitin-Conjugating Enzymes
  • Lipase
  • PNPLA2 protein, human
  • Adenosine Triphosphatases
  • VCP protein, human
  • Valosin Containing Protein
  • Azacitidine